November 11, 2026Stocks·Bullish·biotech
Humacyte plans to submit supplemental BLA for dialysis access in November; to present Phase 3 data at VEITHsymposium
Humacyte says it plans to submit a supplemental BLA for dialysis access in November and will present Phase 3 data at the VEITHsymposium.
Detected & updated continuously · Source: Nebula
Story subjects